CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 29 enrolled
Drug / intervention
BLI800 - Dose 1 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02189850
NCT02189850Phase 2Completed
CompareCT.gov

Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Braintree Laboratories·interventional·Posted Jul 15, 2014·Updated Mar 15, 2021

In Brief

A Phase 2 clinical trial evaluating BLI800 - Dose 1 and BLI800 - Dose 2 for Colonoscopy. Completed, enrolled 29 participants across 5 sites.

Detailed Summary

The purpose o this study is to evaluate the safety, tolerance and efficacy of BLI800 as a bowel preparation prior to colonoscopy in pediatric patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 15, 2014
Enrollment StartJun 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.0 years ago

Interventions

BLI800 - Dose 1drug

BLI800 oral solution

BLI800 - Dose 2drug

BLI800 oral solution